Baird Initiates DexCom, Tandem Diabetes At Outperform On Large Growth Expectations

By: via Benzinga
In a report published Wednesday, Baird analyst Jeff D. Johnson initiated coverage of DexCom, Inc. (NASDAQ: DXCM) and Tandem Diabetes ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.